Provided by Tiger Trade Technology Pte. Ltd.

Mirum Pharmaceuticals, Inc.

96.31
-0.7600-0.78%
Volume:731.68K
Turnover:70.51M
Market Cap:6.25B
PE:-6.84
High:97.89
Open:97.65
Low:95.24
Close:97.07
52wk High:130.00
52wk Low:63.23
Shares:64.93M
Float Shares:56.42M
Volume Ratio:1.56
T/O Rate:1.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-14.0800
EPS(LYR):-0.4700
ROE:-702.97%
ROA:-6.79%
PB:-600.04
PE(LYR):-204.91

Loading ...

Mirum Pharma SVP, Global Controller Jolanda Howe Disposes of 40,000 Common Shares for $4 Million

Reuters
·
Aug 20

Will Mirum Pharmaceuticals' (MIRM) Widening Net Losses Test Its Growth-Focused Investment Narrative?

Simply Wall St.
·
Aug 16

Mirum Pharmaceuticals CEO Christopher Peetz Melepas Saham Senilai $1,99 Juta

Reuters
·
Aug 12

Mirum Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule

Reuters
·
Aug 12

Mirum Pharmaceuticals Laporkan Hibah Inducement 26.050 Opsi Saham Dan 34.590 RSU Untuk 19 Karyawan Baru

Reuters
·
Aug 12

J.P. Morgan Keeps Their Buy Rating on Mirum Pharmaceuticals (MIRM)

TIPRANKS
·
Aug 11

Analysts Offer Insights on Healthcare Companies: Mirum Pharmaceuticals (MIRM) and Encompass Health (EHC)

TIPRANKS
·
Aug 10

Ardelyx Says Q2 Product Revenue at Record High but Ibsrela Revenue Below Expectations

Reuters
·
Aug 07

BioMarin Q2 Revenue Beats Estimates; Raises 2026 Outlook

Reuters
·
Aug 07

Mirum sinks after FDA recommends conducing Phase 3 study

TIPRANKS
·
Aug 07

Mirum Pharmaceuticals is Maintained at Market Outperform by Citizens

Dow Jones
·
Aug 06

Mirum Pharmaceuticals, Inc. : Raymond James Raises Target Price to $183 from $165

THOMSON REUTERS
·
Aug 06

Mirum Pharmaceuticals price target lowered to $137 from $146 at Citizens

TIPRANKS
·
Aug 06

Mirum Pharmaceuticals, Inc. : JP Morgan Cuts Target Price to $118 from $125

THOMSON REUTERS
·
Aug 06

Stock Track | Mirum Pharmaceuticals (MIRM) Plunges 18% in 24 Hours as Q2 Loss Widens Significantly, Misses Estimates

Stock Track
·
Aug 06

Earnings Flash (MIRM) Mirum Pharmaceuticals Posts Q2 Loss -$1.06 per Share

MT Newswires Live
·
Aug 06

Mirum Pharmaceuticals, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Stock Track | Mirum Pharmaceuticals Plunges 14.18% After-Hours as Q2 Loss Widens, Misses Estimates

Stock Track
·
Aug 06

Mirum SVP, Global Controller Jolanda Howe Sells 1,840 Shares for $193,733.6

Reuters
·
Aug 06

Mirum Pharmaceuticals Q2 Sales Rise, Lifts Outlook

Reuters
·
Aug 06